Alhamdi Yasir, Toh Cheng-Hock
Department of Clinical Infection, Microbiology and Immunology, Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Roald Dahl Haemostasis & Thrombosis Centre, Royal Liverpool University Hospital, Liverpool, UK.
F1000Res. 2017 Dec 18;6:2143. doi: 10.12688/f1000research.12498.1. eCollection 2017.
Disseminated intravascular coagulation (DIC) is an acquired condition that develops as a complication of systemic and sustained cell injury in conditions such as sepsis and trauma. It represents major dysregulation and increased thrombin generation . A poor understanding and recognition of the complex interactions in the coagulation, fibrinolytic, inflammatory, and innate immune pathways have resulted in continued poor management and high mortality rates in DIC. This review focuses attention on significant recent advances in our understanding of DIC pathophysiology. In particular, circulating histones and neutrophil extracellular traps fulfil established criteria in DIC pathogenesis. Both are damaging to the vasculature and highly relevant to the cross talk between coagulation and inflammation processes, which can culminate in adverse clinical outcomes. These molecules have a strong potential to be novel biomarkers and therapeutic targets in DIC, which is still considered synonymous with 'death is coming'.
弥散性血管内凝血(DIC)是一种后天性病症,在诸如败血症和创伤等情况下,作为系统性和持续性细胞损伤的并发症而发生。它表现为主要的调节失调和凝血酶生成增加。对凝血、纤维蛋白溶解、炎症和先天免疫途径中复杂相互作用的理解和认识不足,导致DIC的管理持续不佳且死亡率很高。本综述重点关注我们对DIC病理生理学理解的近期重大进展。特别是,循环组蛋白和中性粒细胞胞外陷阱符合DIC发病机制的既定标准。两者都对血管系统有损害,并且与凝血和炎症过程之间的相互作用高度相关,这可能导致不良临床结果。这些分子极有可能成为DIC的新型生物标志物和治疗靶点,而DIC仍被认为是“死亡将至”的同义词。